Hennepin Healthcare Research Institute and University of Minnesota
Hennepin Healthcare Research Institute and University of Minnesota researchers are testing whether immune-targeted therapies such as IL-15 can strengthen T- and B-cell immune responses to malaria vaccination and improve protective immunity against Plasmodium.
What they do
Hennepin Healthcare Research Institute and University of Minnesota researchers are testing whether immune-targeted therapies such as IL-15 can strengthen T- and B-cell immune responses to malaria vaccination and improve protective immunity against Plasmodium.1 Their U.S. R&D is based in Minneapolis, Minnesota.1 The work is at the discovery stage and uses preclinical models to evaluate IL-15 as a malaria vaccine therapeutic and to understand how immune history influences vaccine responses.1
- Minneapolis, MN2,1Research and development
In the field and in development
Partnerships
No endemic-country partnerships are listed.
Who they work with in the United States
- In the atlas
Where this comes from
- 1Confirmed by the organization
- 2experts.umn.edu
- 3experts.umn.edu